DK2687518T3 - Nitrogenholdig mættet heterocyclisk forbindelse - Google Patents
Nitrogenholdig mættet heterocyclisk forbindelseInfo
- Publication number
- DK2687518T3 DK2687518T3 DK12757539.7T DK12757539T DK2687518T3 DK 2687518 T3 DK2687518 T3 DK 2687518T3 DK 12757539 T DK12757539 T DK 12757539T DK 2687518 T3 DK2687518 T3 DK 2687518T3
- Authority
- DK
- Denmark
- Prior art keywords
- nitrogen
- heterocyclic compound
- saturated heterocyclic
- containing saturated
- useful
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
- C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
- C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Urology & Nephrology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2011058338 | 2011-03-16 | ||
PCT/JP2012/056750 WO2012124775A1 (ja) | 2011-03-16 | 2012-03-15 | 含窒素飽和複素環化合物 |
Publications (1)
Publication Number | Publication Date |
---|---|
DK2687518T3 true DK2687518T3 (da) | 2018-01-29 |
Family
ID=46830839
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK12757539.7T DK2687518T3 (da) | 2011-03-16 | 2012-03-15 | Nitrogenholdig mættet heterocyclisk forbindelse |
Country Status (17)
Country | Link |
---|---|
US (2) | US9278944B2 (da) |
EP (1) | EP2687518B1 (da) |
JP (1) | JP5760078B2 (da) |
KR (1) | KR101651722B1 (da) |
CN (1) | CN103562191B (da) |
AU (1) | AU2012229859C1 (da) |
BR (1) | BR112013023480B1 (da) |
CA (1) | CA2828378C (da) |
DK (1) | DK2687518T3 (da) |
ES (1) | ES2652454T3 (da) |
HU (1) | HUE037584T2 (da) |
MX (1) | MX349484B (da) |
PL (1) | PL2687518T3 (da) |
PT (1) | PT2687518T (da) |
RU (1) | RU2595136C2 (da) |
TW (1) | TWI597273B (da) |
WO (1) | WO2012124775A1 (da) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104640847B (zh) * | 2012-09-14 | 2019-10-15 | 上海医药集团股份有限公司 | 新型肾素抑制剂 |
JP5764628B2 (ja) * | 2012-09-14 | 2015-08-19 | 田辺三菱製薬株式会社 | 医薬組成物 |
CN113816952A (zh) * | 2015-12-29 | 2021-12-21 | 上海医药集团股份有限公司 | 吗啉衍生物的盐及其晶型、其制备方法及药物组合物、用途 |
CN109705052B (zh) * | 2019-01-25 | 2020-12-08 | 苏州大学 | 一种制备1,4-二氢噁嗪的方法 |
CN114129569A (zh) * | 2020-09-04 | 2022-03-04 | 上海医药集团股份有限公司 | 一种含氮的饱和杂环化合物的应用 |
WO2022047730A1 (en) | 2020-09-04 | 2022-03-10 | Shanghai Pharmaceuticals Holding Co., Ltd. | Methods to treat inflammatory bowel disease |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0119797D0 (en) * | 2001-08-14 | 2001-10-03 | Glaxo Group Ltd | Chemical compounds |
GB0428526D0 (en) | 2004-12-30 | 2005-02-09 | Novartis Ag | Organic compounds |
GB0505969D0 (en) * | 2005-03-23 | 2005-04-27 | Novartis Ag | Organic compounds |
DE102005017116A1 (de) * | 2005-04-13 | 2006-10-26 | Novartis Ag | Hemmstoffe für Inhibitoren von Apoptose Proteinen (IAP) |
GB0511063D0 (en) | 2005-05-31 | 2005-07-06 | Novartis Ag | Organic compounds |
TWI452044B (zh) * | 2007-06-15 | 2014-09-11 | Mitsubishi Tanabe Pharma Corp | 嗎啉衍生物 |
US8440693B2 (en) | 2009-12-22 | 2013-05-14 | Novartis Ag | Substituted isoquinolinones and quinazolinones |
CN104640847B (zh) * | 2012-09-14 | 2019-10-15 | 上海医药集团股份有限公司 | 新型肾素抑制剂 |
-
2012
- 2012-03-15 MX MX2013010554A patent/MX349484B/es active IP Right Grant
- 2012-03-15 DK DK12757539.7T patent/DK2687518T3/da active
- 2012-03-15 BR BR112013023480-6A patent/BR112013023480B1/pt active IP Right Grant
- 2012-03-15 PL PL12757539T patent/PL2687518T3/pl unknown
- 2012-03-15 WO PCT/JP2012/056750 patent/WO2012124775A1/ja active Application Filing
- 2012-03-15 JP JP2013504772A patent/JP5760078B2/ja active Active
- 2012-03-15 CA CA2828378A patent/CA2828378C/en active Active
- 2012-03-15 ES ES12757539.7T patent/ES2652454T3/es active Active
- 2012-03-15 EP EP12757539.7A patent/EP2687518B1/en active Active
- 2012-03-15 US US14/005,512 patent/US9278944B2/en active Active
- 2012-03-15 HU HUE12757539A patent/HUE037584T2/hu unknown
- 2012-03-15 RU RU2013146012/04A patent/RU2595136C2/ru active
- 2012-03-15 KR KR1020137027214A patent/KR101651722B1/ko active IP Right Grant
- 2012-03-15 PT PT127575397T patent/PT2687518T/pt unknown
- 2012-03-15 AU AU2012229859A patent/AU2012229859C1/en active Active
- 2012-03-15 CN CN201280013626.5A patent/CN103562191B/zh active Active
- 2012-03-16 TW TW101109070A patent/TWI597273B/zh active
-
2016
- 2016-01-12 US US14/993,925 patent/US10155731B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
KR101651722B1 (ko) | 2016-08-26 |
EP2687518B1 (en) | 2017-11-01 |
BR112013023480A8 (pt) | 2019-07-09 |
TW201242955A (en) | 2012-11-01 |
PL2687518T3 (pl) | 2018-04-30 |
AU2012229859C1 (en) | 2020-01-16 |
RU2013146012A (ru) | 2015-05-27 |
MX2013010554A (es) | 2013-12-02 |
CA2828378C (en) | 2017-11-14 |
PT2687518T (pt) | 2018-01-19 |
US20140011807A1 (en) | 2014-01-09 |
US9278944B2 (en) | 2016-03-08 |
CA2828378A1 (en) | 2012-09-20 |
EP2687518A4 (en) | 2014-08-20 |
BR112013023480A2 (pt) | 2017-07-18 |
JPWO2012124775A1 (ja) | 2014-07-24 |
ES2652454T3 (es) | 2018-02-02 |
AU2012229859A1 (en) | 2013-09-19 |
AU2012229859B2 (en) | 2015-07-16 |
KR20130133294A (ko) | 2013-12-06 |
US10155731B2 (en) | 2018-12-18 |
US20160145220A1 (en) | 2016-05-26 |
MX349484B (es) | 2017-07-31 |
CN103562191B (zh) | 2016-03-30 |
TWI597273B (zh) | 2017-09-01 |
BR112013023480B1 (pt) | 2019-10-01 |
EP2687518A1 (en) | 2014-01-22 |
RU2595136C2 (ru) | 2016-08-20 |
HUE037584T2 (hu) | 2018-09-28 |
WO2012124775A1 (ja) | 2012-09-20 |
CN103562191A (zh) | 2014-02-05 |
JP5760078B2 (ja) | 2015-08-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2875877C (en) | Syk inhibitors | |
WO2010105179A3 (en) | Inhibitors of beta-secretase | |
EA201201377A1 (ru) | Определенные аминопиридазины, композиции на их основе и способы их использования | |
EA201700230A1 (ru) | Определенные аминопиридины, композиции на их основе и способы их применения | |
MX2016007861A (es) | Compuestos de ácido dimetilbenzoico. | |
AU2012313888A8 (en) | 3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant IDH | |
RS54730B1 (sr) | Inhibitori beta sekretaze | |
RS53503B1 (en) | AMORPHIC AND CRYSTAL FORM GENZ 112638 HEMITARTARATE AS A GLYCOSILKERAMIDE SYNTHASIS INHIBITOR | |
EA201290632A1 (ru) | Производные бетулина | |
RS53839B1 (en) | SPIROCYCLES AS INHIBITORS OF 11-BETA HYDROXYSTEROID DEHYDROGENASE TYPE 1 | |
AU2012236166A8 (en) | Combinations of AKT inhibitor compounds and chemotherapeutic agents, and methods of use | |
EA201490759A1 (ru) | Ингибиторы протеинкиназы | |
DK2687518T3 (da) | Nitrogenholdig mættet heterocyclisk forbindelse | |
RS54526B1 (en) | USE OF PIRAZOLOSPIROKETONE DERIVATIVES AS ACETYL-COA CARBOXYLASE INHIBITORS | |
WO2010014930A3 (en) | Piperidine derivatives as jak3 inhibitors | |
MX355088B (es) | Inhibidores de tienopirimidina de proteina cinasa c atipica. | |
MY152972A (en) | Azabicyclo compound and salt thereof | |
IN2014DN07509A (da) | ||
MX339455B (es) | Inhibidores de pirimidina y topoisomerasa iv. | |
WO2014031872A3 (en) | Small molecule inhibitors for treating parasitic infections | |
JO3318B1 (ar) | مثبطات bace | |
EA200900924A1 (ru) | Циклизованные производные как ингибиторы eg-5 | |
RS53900B1 (en) | CRYSTAL FORMS OF HYDROCHLORIDE SALTS (4A-R, 9A-S) -1- (1H-BENZOIMIDAZOL-5-CARBONYL) -2,3,4,4A, 9,9A-HEXAHIDRO-1H-INDENO [2,1-B] PIRIDIN-6-CARBONITRILA AND THEIR USE AS A HSD INHIBITOR 1 | |
EA201492255A1 (ru) | Феноксиэтилпиперидиновые соединения | |
IN2014CN04449A (da) |